Modera Wealth Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Modera Wealth Management’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,500	Closed	-$10K	–	122
2016 Q4	$10K	Hold	2,500	–	–	﹤0.01%	108
2016 Q3	$9K	Buy	+2,500	New	+$9.1K	﹤0.01%	112
2016 Q2	–	Sell	-2,500	Closed	-$13K	–	121
2016 Q1	$13K	Buy	+2,500	New	+$20K	﹤0.01%	108

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Modera Wealth Management's CTIC Position: Q1 2017 in Review

Modera Wealth Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2017, closing a stake of 2,500 shares — an estimated $10K sold.

Modera Wealth Management first reported a position in CTIC in Q1 2016 and held it in 3 quarters. The position peaked at $13K in Q1 2016. 47 funds tracked by Wall St. Rank hold CTIC as of Q1 2017.

Modera Wealth Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2017 after selling out during the quarter.
Modera Wealth Management sold 2,500 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2017, an estimated $10K.
Modera Wealth Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2016 and held it in 3 quarters.
Modera Wealth Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $13K in Q1 2016.
47 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2017.

Based on Modera Wealth Management's 13F filing for Q1 2017, filed 11 May 2017.